Mark A Israel Selected Research

Mark A Israel Research Topics

Disease

18	Neoplasms (Cancer) 01/2021 - 03/2002
10	Glioblastoma (Glioblastoma Multiforme) 05/2019 - 03/2002
8	Glioma (Gliomas) 05/2019 - 03/2002
7	Brain Neoplasms (Brain Tumor) 01/2016 - 03/2002
2	Carcinogenesis 02/2009 - 10/2008
1	Genetic Translocation (Chromosomal Translocation) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Multiple Myeloma 01/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021
1	Spinal Cord Neoplasms (Spinal Cord Tumors) 10/2008
1	Astrocytoma (Pilocytic Astrocytoma) 10/2008
1	Medulloblastoma 01/2008
1	Melanoma (Melanoma, Malignant) 03/2007
1	Oligodendroglioma 04/2003

Drug/Important Bio-Agent (IBA)

4	Platelet-Derived Growth FactorIBA 01/2016 - 07/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 02/2009
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017 - 03/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 03/2013
2	MicroRNAs (MicroRNA)IBA 06/2011 - 03/2007
1	carfilzomibIBA 01/2021
1	Bortezomib (Velcade)FDA Link 01/2021
1	Proteasome InhibitorsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	AcidsIBA 05/2019
1	protoporphyrin IXIBA 05/2019
1	Messenger RNA (mRNA)IBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Insulin ReceptorIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	tyrosine receptor (receptor, tyrosine)IBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	E2F Transcription FactorsIBA 01/2016
1	Ubiquitin-Specific ProteasesIBA 01/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2013
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2013
1	Small Interfering RNA (siRNA)IBA 06/2011
1	AgarIBA 06/2011
1	Doxycycline (Periostat)FDA LinkGeneric 10/2008
1	ElementsIBA 10/2008
1	Tetracycline (Achromycin)FDA LinkGeneric 10/2008
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 10/2008
1	IntegrinsIBA 01/2008
1	type I collagen receptorIBA 01/2008
1	Collagen Type I (Type I Collagen)IBA 01/2008
1	involucrinIBA 03/2004
1	ErbB Receptors (EGF Receptor)IBA 04/2003
1	RNA (Ribonucleic Acid)IBA 03/2003
1	Contrast MediaIBA 08/2002
1	GadoliniumIBA 08/2002
1	platelet-derived growth factor AIBA 07/2002
1	LigandsIBA 07/2002
1	CT52923IBA 07/2002
1	platelet-derived growth factor C (PDGF-C)IBA 07/2002
1	Indicators and Reagents (Reagents)IBA 03/2002
1	Monoclonal AntibodiesIBA 03/2002
1	Biomarkers (Surrogate Marker)IBA 03/2002
1	Therapeutic UsesIBA 03/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2002

Therapy/Procedure

9	Therapeutics 01/2018 - 03/2002
1	Transplantation 12/2008